Circulating levels of secretory type II phospholipase A2 predict coronary events in patients with coronary artery disease

Circulation

Volumn 100, Issue 12, 1999, Pages 1280-1284

  Kugiyama, Kiyotaka ^a   Ota, Yasutaka ^a   Takazoe, Keiji ^a   Moriyama, Yasushi ^a   Kawano, Hiroaki ^a   Miyao, Yuji ^a   Sakamoto, Tomohiro ^a   Soejima, Hirofumi ^a   Ogawa, Hisao ^a   Doi, Hideki ^a   Sugiyama, Seigo ^a   Yasue, Hirofumi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Coronary disease; Lipids; Prognosis; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE; PHOSPHOLIPASE A2;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIOIMMUNOASSAY; RISK FACTOR;

EID: 0033592309     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.12.1280     Document Type: Article

References (28)

1. 2. J Biol Chem. 1994;269:13057-13060.
2. 2 - a mediator between proximal and distal effectors of inflammation. Immunol Today. 1991;12:143-146.
3. 2. J Lipid Mediat Cell Signal. 1995;12:119-130.
4. 2 in human atherosclerotic plaques. Atherosclerosis. 1995;118:173-181.
5. 2 in normal and atherosclerotic arteries: activity of the isolated enzyme on low-density lipoproteins. Arterioscler Thromb Vasc Biol. 1997;17:300-309.
6. 2 isoforms in human normal and atherosclerotic arterial wall. Arterioscler Thromb Vasc Biol. 1997;17:2257-2263.
7. Hansson GK, Jonasson L, Seifert PS, Stemme S. Immune mechanisms in atherosclerosis. Arteriosclerosis. 1989;9:567-578.
8. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
9. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995;91:2844-2850.
10. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
11. Hajjar DP, Pomerantz KB. Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid network. FASEB J. 1992;6:2933-2941.
12. Selwyn AP, Kinlay S, Ganz P. Atherogenesis and ischemic heart disease. Am J Cardiol. 1997;80:3H-7H.
13. 2 as an index of disease activity in rheumatoid arthritis: prospective double blind study of 212 patients. J Rheumatol. 1996; 23:1162-1166.
14. 2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis. Gut. 1992;33:914-921.
15. 2 and demonstration of postoperative elevation. Enzyme. 1991;45:200-208.
16. 2 from human spleen. Biochem Biophys Res Commun. 1989;163:42-48.
17. Kugiyama K, Doi H, Motoyama T, Soejima H, Misumi K, Kawano H, Nakagawa O, Yoshimura M, Ogawa H, Matsumura T, Sugiyama S, Nakano T, Nakajima K, Yasue H. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation. 1998;97:2519-2526.
18. The Expert Committee. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
19. 2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells. FEBS Lett. 1990;261:171-174.
20. 2 synthesis in human umbilical vein endothelial cells. J Biol Chem. 1993;268:839-844.
21. 2 generation in rat 3Y1 fibroblasts. J Biol Chem. 1998;273:1733-1740.
22. Kugiyama K, Sakamoto T, Misumi I, Sugiyama S, Ohgushi M, Ogawa H, Horiguchi M, Yasue H. Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells. Circ Res. 1993;73: 335-343.
23. Kume N, Gimbrone MA Jr. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest. 1994;93:907-911.
24. Ohara Y, Peterson TE, Zheng B, Kuo JF, Harrison DG. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler Thromb. 1994;14:1007-1013.
25. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995; 92:657-671.
26. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 1994;331:417-424.
27. Berk BC, Weintraub WS, Alexander RW. Elevation of CRP in "active" CAD. Am J Cardiol. 1990;65:168-172.
28. 2 in T-lymphocyte activation: implication in propagation of inflammatory reaction. Proc Natl Acad Sci U S A. 1993;90:716-719.